1.Bin Liu#,Hongwei Du#, Rachael Rutkowski, Anton Gartner, Xiaochen Wang^*. LAAT-1 is the Lysosomal Lysine/Arginine Transporter that Maintains Amino Acid Homeostasis.Science, 2012, 337: 351-354. (# Co-first authors) (IF56.9)

2.Hongwei Du, Koichi Hirabayashi, Sarah Ahn,et al., Gianpietro Dotti^*. Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.Cancer Cell, 2019, 35 (2): 221-237. (IF50.3)

3.Koichi Hirabayashi#,Hongwei Du#^*, Yang Xu,et al., Gianpietro Dotti^*. Dual-targeting CAR-T cells with optimal co-stimulation and metabolic fitness enhance antitumor activity and prevent escape in solid tumors.Nature Cancer, 2021, 2(9): 904-18. (#Co-first authors,^*Co-corresponding authors). (IF28.5)

4.Hongxia Li, Emily B. Harrison, Huizhong Li, et al., Gianpietro Dotti^*,Hongwei Du^*. Targeting Brain Lesions of Non-Small Cell Lung Cancer by Enhancing CCL2-Mediated CAR-T Cell Migration.Nature Communications, 2022, 13:2154.(IF 16.6)

5.Fei Wang^#, Hui Zou^#, Li Liu, Shiyuan Wang, Haifang Zhao, Zhao Liu, Gang Wang, Zhao Liu, Junnian Zheng, Chuan Xu^*,Hongwei Du^*. TSH Ligand-Based CAR-T Cell Effectively Eradicate TSHR Positive Thyroid Cancer with Favorable Safety Profile.Advanced Science, 2025 (Accepted, in press, IF 14.1)

6.Huizhong Li#, Fei Wang#, Haifang Zhao#, Jiale Cao, Shiyuan Wang, Hongxia Li, Barbara Savoldo, Enyu Rao, Gianpietro Dotti^*,Hongwei Du^*. Preclinical Assessment of the Efficacy of B7-H3 CAR-T in Renal Cell Carcinoma.Molecular Immunology, 2024, 176:1-10.

7.Guanmeng Wang#, Xin Zhou#,et al., Gianpietro Dotti^*,Hongwei Du^*. Fully Human Antibody VHDomains to Generate Mono and Bispecific CAR to Target Solid Tumors.Journal for Immunotherapy of Cancer, 2021, 9(4): e002173. (IF 10.9)

8.Jia Xu, Jie Lei^*, Li-Xin Zhang, Shan Yu, Cheng-He Zhou, Zhi-Gang Xu,Hongwei Du^*, Zhong-Zhu Chen^*. HFIP-driven Schmidt-type reaction enables chromone-3-carbonitriles and its applications.Molecular Diversity, 2024, 11027:1-9.

9.Wei Zou^*,Hongwei Du^*. An essential role of solid-like condensates in Hippo signaling.The Innovation Life, 2025, 3(1):100108.

10.Chuang Sun#, Peishun Shou#,Hongwei Du, Koichi Hirabayashi,et al., Gianpietro Dotti^*.THEMIS-SHP1 Recruitment Tunes the LCK-Mediated Threshold of Activation of Chimeric Antigen Receptor-Redirected T Cells.CancerCell, 2020, 37(2): 216-225. (IF50.3)

11.Niu Liu#, Jiaying Wu#, Enze Deng#, Jianglong Zhong#, Bin Wei#, et al., Lei Cai,Hongwei Du, Sylvan C Baca, Qingpei Huang, Soldano Ferrone, Xinhui Wang^*, Fang Xu^*, Xiaoying Fan^*, Song Fan^*. Immunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results.Nature Medcine, 2025 Aug 25. doi: 10.1038/s41591-025-03873-7.(IF50)

12.Xingcong Ma, Peishun Shou, ChristopherClemens, Yuhui Chen,Hongwei Du, et al., Gianpietro Dotti^*and Yang Xu^*. Interleukin-23 Engineering Improves CAR-T Cell Functions and Safety in Solid Tumors.Nature Biotechnology, 2020, 38(4):448-459. (IF41.7)

13.Andrey Krokhotin#,Hongwei Du#, Koichi Hirabayashi,et al., Gianpietro Dotti^*, andNikolay Dokholyan^*. Computationally Guided Design of Single-chain Variable FragmentImproves Specificity of Chimeric Antigen Receptors.Molecular TherapyOncolytics, 2019, 15: 30-37. (#Co-first authors)

14.Eben I. Lichtman,Hongwei Du, et al., Gianpietro Dotti^*. Pre-Clinical Evaluation of B7-H3-Specific Chimeric Antigen Receptor T-Cells for the Treatment of Acute Myeloid Leukemia.Clinical Cancer Research, 2021, 27:3141-53.(IF11.5)

15.Zhichuan Zhu, Xin Zhou,Hongwei Du, Erica W. Cloer, et al., Gianpietro Dotti, Pengda Liu^*. STING Suppresses Mitochondrial VDAC2 to Govern RCC Growth Independent of Innate Immunity.Advanced Science,2023,10(3):2203718.(IF14.1)

16.Hongwei Du, Jie Han*, Kuixuan Lin, Xiaoming Qu, Wei Wang. Characterization of 11 microsatellite loci derived from genomic sequences of polychaete Capitella capitata complex.Molecular ecology Resources, 2007, 7(6): 1144-1146.